[4-[5-[(2,5-dichlorophenyl)methyl]-7,8-dihydro-6H-pyrazino[2,3-c]pyridazin-3-yl]phenyl]-pyrrolidin-1-ylmethanone
C24H23Cl2N5O — CID 121478283
Data last refreshed: (MolForge compound catalog, from PubChem)
About [4-[5-[(2,5-dichlorophenyl)methyl]-7,8-dihydro-6H-pyrazino[2,3-c]pyridazin-3-yl]phenyl]-pyrrolidin-1-ylmethanone
[4-[5-[(2,5-dichlorophenyl)methyl]-7,8-dihydro-6H-pyrazino[2,3-c]pyridazin-3-yl]phenyl]-pyrrolidin-1-ylmethanone (PubChem CID 121478283) has the molecular formula C24H23Cl2N5O and a molecular weight of 468.39 g/mol. Its IUPAC name is [4-[5-[(2,5-dichlorophenyl)methyl]-7,8-dihydro-6H-pyrazino[2,3-c]pyridazin-3-yl]phenyl]-pyrrolidin-1-ylmethanone.
Molecular Properties
| Compound Name | [4-[5-[(2,5-dichlorophenyl)methyl]-7,8-dihydro-6H-pyrazino[2,3-c]pyridazin-3-yl]phenyl]-pyrrolidin-1-ylmethanone |
|---|---|
| PubChem CID | 121478283 |
| Molecular Formula | C24H23Cl2N5O |
| Molecular Weight | 468.39 g/mol |
| Exact Mass | 467.13 |
| IUPAC Name | [4-[5-[(2,5-dichlorophenyl)methyl]-7,8-dihydro-6H-pyrazino[2,3-c]pyridazin-3-yl]phenyl]-pyrrolidin-1-ylmethanone |
| SMILES | O=C(c1ccc(-c2cc3c(nn2)NCCN3Cc2cc(Cl)ccc2Cl)cc1)N1CCCC1 |
| InChI | InChI=1S/C24H23Cl2N5O/c25-19-7-8-20(26)18(13-19)15-31-12-9-27-23-22(31)14-21(28-29-23)16-3-5-17(6-4-16)24(32)30-10-1-2-11-30/h3-8,13-14H,1-2,9-12,15H2,(H,27,29) |
| InChIKey | IHFIBGCMLLKEHZ-UHFFFAOYSA-N |
| XLogP | 5.12 |
| TPSA | 61.36 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 32 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 468.39 |
| LogP ≤ 5 | 5.12 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 121478283 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.